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Follicular dendritic cells belong to the accessory immune system, and they are
normally present in the germinal center of primary and secondary follicles. Their
major functions include serving as antigen-presenting cells and playing a major
role in the induction and maintenance of the humoral immune response. Tumors
featuring the characteristics of follicular dendritic cells were first described in four
cases reported by Monda, et al.
1 in 1986. Since then, approximately 70 cases have
been reported, most of which are known to be of lymph node origin. However, 24
cases with an extranodal origin were identified in the head and neck region.
2-9 To
date, however, no Korean cases of tumors featuring the characteristics of folli-
cular dendritic cells have been reported. We report a case of this rare entity which
developed in the tonsil, in which the diagnosis and treatment were difficult. Here,
we present our case with a review of the literature.
A 65-year-old male patient visited us with a 1-week-history of discomfort when
swallowing food. A physical examination showed a 1×1 cm round mass on the
surface of the right tonsil (Fig. 1). This mass had an irregular surface but had no
necrotic or ulcerative areas. A neck examination revealed no enlarged lymph
nodes. Diagnostic tonsillectomy was performed. There was no gross evidence of a
residual tumor in the right tonsillar fossa after surgery. The resected right tonsillar
tissue was 3×2×1.7 cm in size (Fig. 2). 
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Follicular dendritic cell sarcoma (FDCS) is unusual, and those with an extranodal
origin in the head and neck region are extremely rare. To date, no cases of tumors
featuring the characteristics of follicular dendritic cells were reported in Korea.
We report a new case of FDCS of the tonsils in a 65-year-old man. A diagnostic
tonsillectomy was performed. Based on histopathologic and immunohistochemical
findings, the patient was diagnosed with FDCS. Adjuvant radiotherapy was
performed due to a high mitotic count. The patient survived with a 2-year disease
free period. The differential diagnosis of a tonsillar mass must include FDCS. In
cases in which FDCS is suspected on histopathologic examination, an immunohis-
tochemical study is essential for the diagnosis.
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INTRODUCTION
CASE REPORTHistopathological examination of the excised tonsil
showed infiltrating tumor tissue and small intermingled
residual lymphocytes. The tumor tissue consisted of
spindle to ovoid cell proliferation forming fascicles, stori-
form patterns, and whorls, including 360 degree whorls.
Individual neoplastic cells showed elongated vesicular
nuclei with distinct nucleoli, plump, slightly eosinophilic
cytoplasm, and indistinct cell borders (Fig. 2). Microcystic
changes containing hemorrhage and occasional multinu-
cleated cells were also seen. Mitotic figures were counted
to 16/10 HPF. Immunohistochemical findings of the
neoplastic cells are positive for CD21 and negative for CK,
LCA, CD20, CD3, ALK-1, CD56, CD68, CD30, and S100
(Fig. 2). Based on histopathologic and immunohistochemi-
cal findings, the patient was diagnosed with follicular
dendritic cell sarcoma (FDCS). Neck computed tomography
(CT) and magnetic resonance image (MRI) after the
tonsillectomy showed no remaining tumor and no abnor-
mal findings on the surrounding structures. Subsequent
staging with positron emission tomography/computed
tomography of the neck, thorax, and abdomen revealed no
regional or distant metastasis. Since this intermediate-
grade malignancy is associated with a high risk of local
recurrence, we prescribed radiotherapy at the primary site
as adjunctive therapy. Postoperative radiotherapy of 5,400
cGy with 180 cGy fractions delivered over 6 weeks was
applied to the right tonsillar region. The patient survived
with a 2-year disease free period. 
FDCS is a rare neoplasm arising not only from lymph nodes
but also extranodally, either as acquired lymphoid tissue or
as part of the organized constitutive lymphoid tissue. In
most cases, the tumor occurs in the lymph nodes of the
neck, mediastinum, and axilla. In approximately 30% of
cases, the tumor develops in such extranodal sites as the
liver, tonsil, and intra-abdominal soft tissue.
10 A similar
prevalence was seen between male and female patients,
and the median age of the patients was 47 years with a
wide age range of 14-77 years.
11,12 FDCS is typically
described as a painless, slow-growing, well-circumscribed
mass. A histopathological diagnosis of FDCS can be made
homogeneously. Microscopically, FDCS is composed of
oval to spindle cells with eosinophilic cytoplasm arranged
in sheets, fascicles, and whorls, sometimes admixed with
foci showing a storiform pattern of growth, suggesting a
diagnosis of sarcoma. Tumor cells are typically chara-
cterized by mixtures of small lymphocytes, which can lead
to a misdiagnosis of lymphoma. Immunophenotypes of
FDCS are positive for CD21, CD35, Ki-M4p, and Ki-
FDC1p, and are variably positive to vimentin, S-100 pro-
tein, CD68 and specific muscle actin (2, 10, 15, 16). Of
these, CD21 and CD35 are the most useful antibodies be-
cause of their sensitivity and specificity. These antibodies
can be used individually, and their sensitivity increases
when they are used as a “cocktail”.
8 In the current case,
microscopic findings were consistent with those above and
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Fig. 1. Preoperative endoscopic finding shows irregular round mass in right
tonsil (superior view).
Fig. 2. (A) Surgical specimen shows irregular round mass measuring 3×2×1.7 cm in size on right tonsil. (B) The tumor tissue consisted of spindle to ovoid cell
proliferation forming fascicles, storiform patterns, and whorls. Individual neoplastic cells show elongated vesicular nuclei with distinct nucleoli, plump, slightly
eosinophilic cytoplasm, and indistinct cell borders (HE stain×400). (C) Immunohistochemical findings of the neoplastic cells are positive for CD21 (×400).
ABCwere positive for CD21. This led to the diagnosis. 
Differential diagnoses include extracranial meningioma,
peripheral nerve sheath tumor, malignant melanoma,
ectopic thymoma, metastatic carcinoma, malignant fibrous
histiocytoma, large cell lymphoma, and interstitial reti-
culum cell sarcoma.
8,9 The diagnosis of FDCS can be made
based on microscopic and immunohistochemical findings.
In the immunohistochemical study of poorly differentiated
tumors, however, markers for FDCS are not generally used.
Therefore, in cases in which FDCS occurred in extranodal
sites, the diagnosis of these rare tumors cannot be made
easily.
4,6,7
For the management of tonsillar FDCS, a wide excision
of the tumor was performed. In cases in which metastasis
to regional lymph nodes is suspected on imaging studies, a
neck dissection is recommended.
3 In the current case, a neck
dissection was not performed because no findings sugges-
tive of metastasis to the neck lymph nodes were observed
on imaging studies following the diagnostic tonsillectomy. 
Adjuvant radiotherapy or chemotherapy can be applied
to cases with adverse pathologic features and in cases of
advanced or incompletely resected lesions. FDCS is consi-
dered a low- or intermediate-grade malignancy.
2,3,7-9 Pre-
vious reports characterized the criteria for a poor prognosis
as follows: tumor size of > 6 cm, nuclear pleomorphism,
high mitotic count (≥ 5 per 10 high-power field), intraab-
dominal location, lack of adjuvant therapy, coagulation
necrosis, and significant cellular atypias.
2,5 In the current
case, the adjuvant radiotherapy was performed due to a
high mitotic count. 
FDCS is a rare tumor which has been frequently des-
cribed in recent studies and can be misdiagnosed at a high
rate in cases which occur in extranodal sites. Accordingly,
a histopathologic examination is mandatory in cases in
which the mass developed in the tonsils. A differential
diagnosis of a tonsillar mass should include FDCS. In
cases in which FDCS is suspected on histopathologic
examination, an immunohistochemical study is essential
for the differential diagnosis.
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